Actavis (ACT) Announces FDA Approval for VIBERZI, Plans Launch in Q1 2016

StreetInsider.com  Actavis plc (NYSE: ACT) announced today that VIBERZI™ (eluxadoline) was approved by the Food and Drug Administration (FDA) as a twice-daily, … read more news

Eli Lilly & Co. (LLY) Announces FDA Approval of Higher-Concentration Humalog KwikPen

The U.S. Food and Drug Administration (FDA) has approved Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL; U-200), a pre-filled pen …read more

Get Med Career News in your Inbox!

If you want to keep up with the latest news and career tips in the Medical Field subscribe today!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.